Literature DB >> 10992727

Acquired hemophilia successfully treated with oral immunosuppressive therapy.

J J Lee1, I J Chung, M R Park, D H Yang, S H Cho, D W Ryang, H J Kim.   

Abstract

Acquired hemophilia is a rare disorder associated with serious bleeding in nonhemophilic patients. We had a 40-year-old woman who was diagnosed as acquired hemophilia with a factor VIII inhibitor level of 27.5 BU/mL. She was presented with gross hematuria and severe right shoulder pain, and was successfully treated with daily oral cyclophosphamide and prednisone for 2 weeks. After the remission, the doses of prednisone and cyclophosphamide were slowly decreased and she remained in complete remission without further bleeding episodes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10992727      PMCID: PMC4531764          DOI: 10.3904/kjim.2000.15.2.135

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  10 in total

Review 1.  Acquired inhibitors in malignant and nonmalignant disease states.

Authors:  M B Hultin
Journal:  Am J Med       Date:  1991-11-04       Impact factor: 4.965

Review 2.  Factor VIII inhibitors: structure and function in autoantibody and hemophilia A patients.

Authors:  L W Hoyer; D Scandella
Journal:  Semin Hematol       Date:  1994-04       Impact factor: 3.851

3.  The treatment of acquired factor VIII inhibitors: worldwide experience with porcine factor VIII concentrate. International Acquired Hemophilia Study Group.

Authors:  C M Kessler; C A Ludlam
Journal:  Semin Hematol       Date:  1993-04       Impact factor: 3.851

4.  Immunosuppression of patients with acquired factor VIII inhibitors.

Authors:  D Green
Journal:  Semin Hematol       Date:  1994-04       Impact factor: 3.851

5.  Treatment of acquired hemophilia.

Authors:  C A Ludlam; A E Morrison; C Kessler
Journal:  Semin Hematol       Date:  1994-04       Impact factor: 3.851

6.  Successful treatment of acquired hemophilia with oral immunosuppressive therapy.

Authors:  L G Shaffer; M D Phillips
Journal:  Ann Intern Med       Date:  1997-08-01       Impact factor: 25.391

7.  Acquired factor VIII inhibitors--successful treatment with an oral outpatient regimen.

Authors:  R L Bayer; S M Lichtman; S L Allen; D R Budman; A Buchbinder; J Fetten; J Kolitz; J Loscalzo
Journal:  Am J Hematol       Date:  1999-01       Impact factor: 10.047

8.  A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies.

Authors:  D Green; A W Rademaker; E Briët
Journal:  Thromb Haemost       Date:  1993-11-15       Impact factor: 5.249

9.  Combination immunosuppressive therapy after factor VIII infusion for acquired factor VIII inhibitor.

Authors:  E C Lian; A F Larcada; A Y Chiu
Journal:  Ann Intern Med       Date:  1989-05-15       Impact factor: 25.391

10.  An introduction to factor VIII inhibitors: the detection and quantitation.

Authors:  C M Kessler
Journal:  Am J Med       Date:  1991-11-04       Impact factor: 4.965

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.